Übersicht · Eingereicht: —
UPC_APP_1178/2025
REMOTE MONITORING OF ANALYTE MEASUREMENTS
Prozessuale & UnteranträgeRücknahmeanträgeCourt of AppealApplication Rop 265—Vergleich erfolgt: Nach Hauptsache
Parteien
Kläger
- Dexcom Inc.(Dexcom Group)
Vertreter: Anne-Charlotte le Bihan (Bird & Bird); Laurent Labatte (Bird & Bird); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)
Beklagte
- Abbott Laboratories(Abbott Group)
- Abbott Diabetes Care Inc.(Abbott Group)
- Abbott France (S.A.S.)(Abbott Group)
- Abbott (S.A./N.V.)(Abbott Group)
- Abbott B.V.(Abbott Group)
- Abbott s.r.l.(Abbott Group)
- Abbott Scandinavia Aktiebolag(Abbott Group)
- Abbott Oy(Abbott Group)
- Abbott Gesellschaft m.b.H.(Abbott Group)
- Abbott Laboratories A/S(Abbott Group)
- Abbott GmbH(Abbott Group)
- Abbott Diagnostics GmbH(Abbott Group)
- Abbott Logistics B.V.(Abbott Group)
- Newyu, Inc.(Abbott Group)
Vertreter: Christian Dekoninck (Taylor Wessing); François Pochart (August Debouzy); Wim Maas (Taylor Wessing); Eelco Bergsma (Taylor Wessing)
Richter
- Rian KaldenPresiding judge and legally qualified judge
- Ingeborg SimonssonLegally qualified judge and judge-rapporteur
- Patricia RombachLegally qualified judge
Patente
- EP 3 831 282
CPC-Codes: A61B5/7282, A61B5/7465, G16H40/20, H04L67/12, G16H50/70, A61B5/145, G16H40/63, G16H50/20, A61B5/0015, A61B5/0004, A61B5/14532, A61B5/14546…
Sektor: Healthcare Informatics
Ausgang
Zurückgenommen
Eingereicht: —
Erste Entscheidung: 24. Jan. 2025
Sprache: —
Vergleich erfolgt: Nach Hauptsache
Court of Appeal Panel 2 order permitting DexCom's withdrawal of its infringement appeal and declaring the proceedings closed. Background: the Paris Local Division had revoked EP 3 831 282 (continuous glucose monitoring) and dismissed all DexCom infringement claims; DexCom appealed but then applied to withdraw the action including the appeal. The withdrawal was permitted, proceedings closed, and 60% of appeal court fees refunded to DexCom. No costs decision required.